Ying Feng

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

Sergei I. Grivennikov, Kepeng Wang, Daniel Mucida et al. · Nature · 2012 · 1.3K citations · Full text

Medicine, Immunology, Oncology +12

p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes

Guido T. Bommer, Isabelle Gerin, Ying Feng et al. · Current Biology · 2007 · 1.1K citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +14

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer

Robert J. Cardnell, Ying Feng, Lixia Diao et al. · Clinical Cancer Research · 2013 · 180 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery and Characterization of (8<i>S</i>,9<i>R</i>)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1<i>H</i>-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3<i>H</i>-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent

Bing Wang, Daniel I. Chu, Ying Feng et al. · Journal of Medicinal Chemistry · 2015 · 170 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer

Jia‐Zhou Liu, Yilin Hu, Ying Feng et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 142 citations · Full text

Life Sciences, Cancer Biology, Oncology +17